Author | Cheryl Guttman Krader, BS, Pharm


Dual JAK/SYK inhibitor a promising systemic treatment for chronic hand eczema

June 23, 2020

Gusacitinib, an investigational oral Janus kinase/spleen tyrosine kinase inhibitor, demonstrated statistical superiority compared with placebo for improving chronic hand eczema in a phase 2b study.

Study characterizes safety of pediatric psoriasis treatments

December 07, 2017

A retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.

Energy-based treatment advantages for acne

May 09, 2016

Two novel energy-based approaches are ushering in a new era in acne treatment. One expert addresses the role these devices may play.

Data support acne dietary triggers

April 12, 2016

New findings support dietary and supplementation practices that can influence acne. One expert discusses modifications in context of protocols for managing the condition.